Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. | Reflects a value of $215,000 divided by the closing price of common stock on the date of grant. | Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. | Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
Smith Cathy R
Director·Direct
Grant · Acquire
Deferred Stock UnitsDerivative
Shares+2.21K
Price$0.00
Total Value$0
Shares Owned After6.89K
Transaction DateMay 7, 2026
Footnotes ▸
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. | Deferred stock units were granted in lieu of 100% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $125,000 (representing 100% of the amount of the non-employee director compensation program's cash retainer) divided by the closing price of the common stock on the date of grant. | Deferred stock units were granted in lieu of 100% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $125,000 (representing 100% of the amount of the non-employee director compensation program's cash retainer) divided by the closing price of the common stock on the date of grant. | Deferred stock units were granted in lieu of 100% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $125,000 (representing 100% of the amount of the non-employee director compensation program's cash retainer) divided by the closing price of the common stock on the date of grant.
Post-Transaction Holdings
Smith Cathy R
Security
Shares
Change
Deferred Stock Units
4.68K
+6.01K (-451.80%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-05-07
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
--- Reporting Owner ---
Name: Smith Cathy R
CIK: 0001322028
Role: Director
--- Derivative Transactions ---
[Transaction #1]
Security: Deferred Stock Units
Date: 2026-05-07 | Code: A (Grant or award)
Shares: +3,800 | Price: $0.00
Shares Owned After: 4,679 | Ownership: D (Direct)
Footnotes:
[F1] Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
[F2] Reflects a value of $215,000 divided by the closing price of common stock on the date of grant.
[F3] Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
[F3] Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
[Transaction #2]
Security: Deferred Stock Units
Date: 2026-05-07 | Code: A (Grant or award)
Shares: +2,209 | Price: $0.00
Shares Owned After: 6,888 | Ownership: D (Direct)
Footnotes:
[F1] Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
[F4] Deferred stock units were granted in lieu of 100% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $125,000 (representing 100% of the amount of the non-employee director compensation program's cash retainer) divided by the closing price of the common stock on the date of grant.
[F4] Deferred stock units were granted in lieu of 100% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $125,000 (representing 100% of the amount of the non-employee director compensation program's cash retainer) divided by the closing price of the common stock on the date of grant.
[F4] Deferred stock units were granted in lieu of 100% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $125,000 (representing 100% of the amount of the non-employee director compensation program's cash retainer) divided by the closing price of the common stock on the date of grant.
--- Footnotes (Complete Index) ---
F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Reflects a value of $215,000 divided by the closing price of common stock on the date of grant.
F3: Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
F4: Deferred stock units were granted in lieu of 100% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $125,000 (representing 100% of the amount of the non-employee director compensation program's cash retainer) divided by the closing price of the common stock on the date of grant.
--- Signature ---
/s/ /s/ Susan Thompson, Attorney-in-Fact (2026-05-11)
